RBC Capital on Chemours (CC): 'we continue to expect CC's APM portfolio transformation from AM to PS to drive stability'

March 31, 2026 2:13 PM

RBC Capital analyst Arun Viswanathan reiterated an Outperform rating and $21.00 price target on Chemours (NYSE: CC).The analyst comments "Overall ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

RBC Capital on Chemours (CC): 'we continue to expect CC's APM portfolio transformation from AM to PS to drive stability'

Categories